Abstract
The number needed to treat (NNT) is an increasingly popular way of presenting the effects of treatment. However, the NNT varies markedly depending on the baseline risk of patients, the outcome considered, and the clinical setting. Furthermore geographic and secular trends make the NNT unstable between places and over time. Particular caution is needed in deriving the NNT from pooled absolute risk differences in meta-analysis. In general, the NNT should be calculated by applying the relative risk reduction on treatment estimated by trials or meta-analysis to populations of specified absolute high, average or low risk to illustrate a range of possible NNTs.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
Trials Open Access 12 August 2010
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ebrahim, S., Smith, G. The ‘number need to treat’: does it help clinical decision making?. J Hum Hypertens 13, 721–724 (1999). https://doi.org/10.1038/sj.jhh.1000919
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1000919